Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $28.14 Million Stock Holdings in Stryker Corporation $SYK

Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its holdings in shares of Stryker Corporation (NYSE:SYK) by 3.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 80,059 shares of the medical technology company’s stock after selling 2,566 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Stryker were worth $28,138,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Czech National Bank raised its holdings in shares of Stryker by 3.9% in the 4th quarter. Czech National Bank now owns 90,755 shares of the medical technology company’s stock valued at $31,898,000 after purchasing an additional 3,366 shares during the period. Davis R M Inc. raised its holdings in shares of Stryker by 1.8% in the 3rd quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock valued at $51,285,000 after purchasing an additional 2,512 shares during the period. Terra Alpha Investments LLC bought a new stake in shares of Stryker during the 3rd quarter worth about $1,216,000. Kepler Cheuvreux Suisse SA bought a new stake in shares of Stryker during the 3rd quarter worth about $27,952,000. Finally, Daymark Wealth Partners LLC raised its holdings in Stryker by 436.0% in the 4th quarter. Daymark Wealth Partners LLC now owns 45,863 shares of the medical technology company’s stock valued at $16,119,000 after acquiring an additional 37,307 shares during the period. 77.09% of the stock is owned by institutional investors.

Stryker Stock Performance

Shares of NYSE:SYK opened at $305.73 on Monday. The company’s 50 day moving average price is $321.82 and its two-hundred day moving average price is $348.10. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The firm has a market cap of $117.21 billion, a PE ratio of 35.39, a PEG ratio of 1.92 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same quarter in the previous year, the company earned $2.84 EPS. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts predict that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

Analyst Ratings Changes

Several research firms have weighed in on SYK. Barclays lowered their price target on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Leerink Partners began coverage on shares of Stryker in a report on Monday, April 13th. They issued an “outperform” rating and a $410.00 price target on the stock. The Goldman Sachs Group reissued a “neutral” rating and issued a $361.00 price target on shares of Stryker in a report on Friday, May 1st. Truist Financial reissued a “hold” rating and issued a $330.00 price target (down from $380.00) on shares of Stryker in a report on Monday, May 4th. Finally, Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $395.48.

Insiders Place Their Bets

In other Stryker news, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the transaction, the vice president owned 10,582 shares in the company, valued at $3,247,298.34. This represents a 30.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. The trade was a 13.87% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 323,264 shares of company stock worth $100,659,489 in the last quarter. Corporate insiders own 4.60% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.